Phase 1 Study of CEP-37250/KHK2804, a Tumor-specific Anti-glycoconjugate Monoclonal Antibody, in Patients with Advanced Solid Tumors

Monica M. Mita, John Nemunaitis, Juneko Grilley-Olson, Bassil El-Rayes, Tanios Bekaii-Saab, R. Donald Harvey, John Marshall, Xiaoping Zhang, Vincent Strout

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 Study of CEP-37250/KHK2804, a Tumor-specific Anti-glycoconjugate Monoclonal Antibody, in Patients with Advanced Solid Tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences